nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA9—kidney cancer	0.293	0.527	CbGaD
Topiramate—CA2—kidney cancer	0.263	0.473	CbGaD
Topiramate—CYP3A4—Everolimus—kidney cancer	0.0127	0.26	CbGbCtD
Topiramate—CYP3A4—Temsirolimus—kidney cancer	0.00857	0.176	CbGbCtD
Topiramate—CA2—collecting duct of renal tubule—kidney cancer	0.00564	0.163	CbGeAlD
Topiramate—CYP2C19—Sorafenib—kidney cancer	0.00541	0.111	CbGbCtD
Topiramate—CYP3A4—Pazopanib—kidney cancer	0.0045	0.0924	CbGbCtD
Topiramate—GRIK4—renal system—kidney cancer	0.00416	0.12	CbGeAlD
Topiramate—GRIK4—kidney—kidney cancer	0.00402	0.116	CbGeAlD
Topiramate—CYP3A4—Erlotinib—kidney cancer	0.00321	0.0659	CbGbCtD
Topiramate—CYP3A4—Paclitaxel—kidney cancer	0.00294	0.0603	CbGbCtD
Topiramate—GRIK5—cortex of kidney—kidney cancer	0.00285	0.0823	CbGeAlD
Topiramate—CYP3A4—Sorafenib—kidney cancer	0.00261	0.0536	CbGbCtD
Topiramate—CYP3A4—Vinblastine—kidney cancer	0.00258	0.0529	CbGbCtD
Topiramate—CYP3A4—Vincristine—kidney cancer	0.00254	0.052	CbGbCtD
Topiramate—CYP2C19—urine—kidney cancer	0.0022	0.0633	CbGeAlD
Topiramate—CYP3A4—Sunitinib—kidney cancer	0.00212	0.0434	CbGbCtD
Topiramate—CYP3A4—Doxorubicin—kidney cancer	0.00159	0.0325	CbGbCtD
Topiramate—CA7—renal system—kidney cancer	0.00148	0.0426	CbGeAlD
Topiramate—CA7—kidney—kidney cancer	0.00143	0.0411	CbGeAlD
Topiramate—CYP3A4—urine—kidney cancer	0.0013	0.0374	CbGeAlD
Topiramate—CA12—renal system—kidney cancer	0.000959	0.0276	CbGeAlD
Topiramate—CA12—kidney—kidney cancer	0.000927	0.0267	CbGeAlD
Topiramate—CA5B—gonad—kidney cancer	0.000771	0.0222	CbGeAlD
Topiramate—CA5B—cardiac atrium—kidney cancer	0.00077	0.0222	CbGeAlD
Topiramate—CA1—renal system—kidney cancer	0.00076	0.0219	CbGeAlD
Topiramate—SCN5A—cardiac atrium—kidney cancer	0.000747	0.0215	CbGeAlD
Topiramate—CA1—kidney—kidney cancer	0.000734	0.0212	CbGeAlD
Topiramate—CA4—nephron tubule—kidney cancer	0.000653	0.0188	CbGeAlD
Topiramate—CA4—renal system—kidney cancer	0.000594	0.0171	CbGeAlD
Topiramate—CA4—kidney—kidney cancer	0.000574	0.0166	CbGeAlD
Topiramate—CA4—cortex of kidney—kidney cancer	0.000559	0.0161	CbGeAlD
Topiramate—CA2—nephron tubule—kidney cancer	0.000542	0.0156	CbGeAlD
Topiramate—CA4—cardiac atrium—kidney cancer	0.000532	0.0153	CbGeAlD
Topiramate—CA2—renal system—kidney cancer	0.000492	0.0142	CbGeAlD
Topiramate—CA2—kidney—kidney cancer	0.000476	0.0137	CbGeAlD
Topiramate—CA2—cortex of kidney—kidney cancer	0.000464	0.0134	CbGeAlD
Topiramate—CA2—cardiac atrium—kidney cancer	0.000441	0.0127	CbGeAlD
Topiramate—CYP3A4—renal system—kidney cancer	0.000318	0.00916	CbGeAlD
Topiramate—CYP3A4—kidney—kidney cancer	0.000307	0.00885	CbGeAlD
Topiramate—Shock—Paclitaxel—kidney cancer	4.55e-05	0.000185	CcSEcCtD
Topiramate—Vomiting—Sorafenib—kidney cancer	4.55e-05	0.000185	CcSEcCtD
Topiramate—Orthostatic hypotension—Doxorubicin—kidney cancer	4.55e-05	0.000185	CcSEcCtD
Topiramate—Abdominal pain upper—Doxorubicin—kidney cancer	4.55e-05	0.000185	CcSEcCtD
Topiramate—Nervous system disorder—Paclitaxel—kidney cancer	4.54e-05	0.000184	CcSEcCtD
Topiramate—Hypokalaemia—Doxorubicin—kidney cancer	4.53e-05	0.000184	CcSEcCtD
Topiramate—Thrombocytopenia—Paclitaxel—kidney cancer	4.53e-05	0.000184	CcSEcCtD
Topiramate—Tachycardia—Paclitaxel—kidney cancer	4.51e-05	0.000183	CcSEcCtD
Topiramate—Rash—Sorafenib—kidney cancer	4.51e-05	0.000183	CcSEcCtD
Topiramate—Dermatitis—Sorafenib—kidney cancer	4.51e-05	0.000183	CcSEcCtD
Topiramate—Back pain—Capecitabine—kidney cancer	4.5e-05	0.000183	CcSEcCtD
Topiramate—Breast disorder—Doxorubicin—kidney cancer	4.5e-05	0.000183	CcSEcCtD
Topiramate—Skin disorder—Paclitaxel—kidney cancer	4.49e-05	0.000182	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.48e-05	0.000182	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.48e-05	0.000182	CcSEcCtD
Topiramate—Headache—Sorafenib—kidney cancer	4.48e-05	0.000182	CcSEcCtD
Topiramate—Muscle spasms—Capecitabine—kidney cancer	4.47e-05	0.000181	CcSEcCtD
Topiramate—Hyperhidrosis—Paclitaxel—kidney cancer	4.47e-05	0.000181	CcSEcCtD
Topiramate—Diarrhoea—Dactinomycin—kidney cancer	4.46e-05	0.000181	CcSEcCtD
Topiramate—Nasopharyngitis—Doxorubicin—kidney cancer	4.45e-05	0.000181	CcSEcCtD
Topiramate—Anorexia—Paclitaxel—kidney cancer	4.41e-05	0.000179	CcSEcCtD
Topiramate—Gastritis—Doxorubicin—kidney cancer	4.41e-05	0.000179	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.39e-05	0.000178	CcSEcCtD
Topiramate—Muscular weakness—Doxorubicin—kidney cancer	4.39e-05	0.000178	CcSEcCtD
Topiramate—Vision blurred—Capecitabine—kidney cancer	4.38e-05	0.000178	CcSEcCtD
Topiramate—Vomiting—Sunitinib—kidney cancer	4.38e-05	0.000178	CcSEcCtD
Topiramate—Body temperature increased—Gemcitabine—kidney cancer	4.37e-05	0.000177	CcSEcCtD
Topiramate—Tremor—Capecitabine—kidney cancer	4.36e-05	0.000177	CcSEcCtD
Topiramate—Rash—Sunitinib—kidney cancer	4.34e-05	0.000176	CcSEcCtD
Topiramate—Dermatitis—Sunitinib—kidney cancer	4.34e-05	0.000176	CcSEcCtD
Topiramate—Abdominal distension—Doxorubicin—kidney cancer	4.33e-05	0.000176	CcSEcCtD
Topiramate—Hypotension—Paclitaxel—kidney cancer	4.32e-05	0.000175	CcSEcCtD
Topiramate—Ill-defined disorder—Capecitabine—kidney cancer	4.32e-05	0.000175	CcSEcCtD
Topiramate—Headache—Sunitinib—kidney cancer	4.31e-05	0.000175	CcSEcCtD
Topiramate—Asthma—Doxorubicin—kidney cancer	4.3e-05	0.000175	CcSEcCtD
Topiramate—Dysphagia—Doxorubicin—kidney cancer	4.3e-05	0.000175	CcSEcCtD
Topiramate—Anaemia—Capecitabine—kidney cancer	4.3e-05	0.000174	CcSEcCtD
Topiramate—Hypersensitivity—Vincristine—kidney cancer	4.29e-05	0.000174	CcSEcCtD
Topiramate—Eosinophilia—Doxorubicin—kidney cancer	4.26e-05	0.000173	CcSEcCtD
Topiramate—Nausea—Sorafenib—kidney cancer	4.25e-05	0.000172	CcSEcCtD
Topiramate—Pancreatitis—Doxorubicin—kidney cancer	4.22e-05	0.000171	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.21e-05	0.000171	CcSEcCtD
Topiramate—Malaise—Capecitabine—kidney cancer	4.19e-05	0.00017	CcSEcCtD
Topiramate—Angina pectoris—Doxorubicin—kidney cancer	4.19e-05	0.00017	CcSEcCtD
Topiramate—Insomnia—Paclitaxel—kidney cancer	4.18e-05	0.00017	CcSEcCtD
Topiramate—Vertigo—Capecitabine—kidney cancer	4.18e-05	0.00017	CcSEcCtD
Topiramate—Asthenia—Vincristine—kidney cancer	4.18e-05	0.00017	CcSEcCtD
Topiramate—Syncope—Capecitabine—kidney cancer	4.17e-05	0.000169	CcSEcCtD
Topiramate—Leukopenia—Capecitabine—kidney cancer	4.16e-05	0.000169	CcSEcCtD
Topiramate—Paraesthesia—Paclitaxel—kidney cancer	4.15e-05	0.000169	CcSEcCtD
Topiramate—Vomiting—Dactinomycin—kidney cancer	4.14e-05	0.000168	CcSEcCtD
Topiramate—Bronchitis—Doxorubicin—kidney cancer	4.14e-05	0.000168	CcSEcCtD
Topiramate—Dyspnoea—Paclitaxel—kidney cancer	4.12e-05	0.000167	CcSEcCtD
Topiramate—Somnolence—Paclitaxel—kidney cancer	4.11e-05	0.000167	CcSEcCtD
Topiramate—Palpitations—Capecitabine—kidney cancer	4.11e-05	0.000167	CcSEcCtD
Topiramate—Rash—Dactinomycin—kidney cancer	4.11e-05	0.000167	CcSEcCtD
Topiramate—Nausea—Sunitinib—kidney cancer	4.09e-05	0.000166	CcSEcCtD
Topiramate—Loss of consciousness—Capecitabine—kidney cancer	4.09e-05	0.000166	CcSEcCtD
Topiramate—Pancytopenia—Doxorubicin—kidney cancer	4.09e-05	0.000166	CcSEcCtD
Topiramate—Dyspepsia—Paclitaxel—kidney cancer	4.07e-05	0.000165	CcSEcCtD
Topiramate—Cough—Capecitabine—kidney cancer	4.06e-05	0.000165	CcSEcCtD
Topiramate—Dysuria—Doxorubicin—kidney cancer	4.02e-05	0.000163	CcSEcCtD
Topiramate—Neutropenia—Doxorubicin—kidney cancer	4.02e-05	0.000163	CcSEcCtD
Topiramate—Decreased appetite—Paclitaxel—kidney cancer	4.02e-05	0.000163	CcSEcCtD
Topiramate—Hypertension—Capecitabine—kidney cancer	4.02e-05	0.000163	CcSEcCtD
Topiramate—Upper respiratory tract infection—Doxorubicin—kidney cancer	4e-05	0.000162	CcSEcCtD
Topiramate—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.99e-05	0.000162	CcSEcCtD
Topiramate—Fatigue—Paclitaxel—kidney cancer	3.99e-05	0.000162	CcSEcCtD
Topiramate—Diarrhoea—Vincristine—kidney cancer	3.98e-05	0.000162	CcSEcCtD
Topiramate—Pollakiuria—Doxorubicin—kidney cancer	3.97e-05	0.000161	CcSEcCtD
Topiramate—Asthenia—Gemcitabine—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Myalgia—Capecitabine—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Chest pain—Capecitabine—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Arthralgia—Capecitabine—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Pain—Paclitaxel—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Constipation—Paclitaxel—kidney cancer	3.96e-05	0.000161	CcSEcCtD
Topiramate—Anxiety—Capecitabine—kidney cancer	3.95e-05	0.00016	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.93e-05	0.00016	CcSEcCtD
Topiramate—Photosensitivity reaction—Doxorubicin—kidney cancer	3.93e-05	0.000159	CcSEcCtD
Topiramate—Weight increased—Doxorubicin—kidney cancer	3.92e-05	0.000159	CcSEcCtD
Topiramate—Discomfort—Capecitabine—kidney cancer	3.91e-05	0.000159	CcSEcCtD
Topiramate—Pruritus—Gemcitabine—kidney cancer	3.91e-05	0.000159	CcSEcCtD
Topiramate—Weight decreased—Doxorubicin—kidney cancer	3.89e-05	0.000158	CcSEcCtD
Topiramate—Hyperglycaemia—Doxorubicin—kidney cancer	3.88e-05	0.000158	CcSEcCtD
Topiramate—Dry mouth—Capecitabine—kidney cancer	3.87e-05	0.000157	CcSEcCtD
Topiramate—Nausea—Dactinomycin—kidney cancer	3.87e-05	0.000157	CcSEcCtD
Topiramate—Pneumonia—Doxorubicin—kidney cancer	3.86e-05	0.000157	CcSEcCtD
Topiramate—Dizziness—Vincristine—kidney cancer	3.85e-05	0.000156	CcSEcCtD
Topiramate—Infestation—Doxorubicin—kidney cancer	3.84e-05	0.000156	CcSEcCtD
Topiramate—Infestation NOS—Doxorubicin—kidney cancer	3.84e-05	0.000156	CcSEcCtD
Topiramate—Confusional state—Capecitabine—kidney cancer	3.83e-05	0.000155	CcSEcCtD
Topiramate—Feeling abnormal—Paclitaxel—kidney cancer	3.81e-05	0.000155	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.8e-05	0.000154	CcSEcCtD
Topiramate—Oedema—Capecitabine—kidney cancer	3.8e-05	0.000154	CcSEcCtD
Topiramate—Gastrointestinal pain—Paclitaxel—kidney cancer	3.78e-05	0.000153	CcSEcCtD
Topiramate—Diarrhoea—Gemcitabine—kidney cancer	3.78e-05	0.000153	CcSEcCtD
Topiramate—Renal failure—Doxorubicin—kidney cancer	3.77e-05	0.000153	CcSEcCtD
Topiramate—Infection—Capecitabine—kidney cancer	3.77e-05	0.000153	CcSEcCtD
Topiramate—Neuropathy peripheral—Doxorubicin—kidney cancer	3.76e-05	0.000153	CcSEcCtD
Topiramate—Stomatitis—Doxorubicin—kidney cancer	3.74e-05	0.000152	CcSEcCtD
Topiramate—Shock—Capecitabine—kidney cancer	3.73e-05	0.000152	CcSEcCtD
Topiramate—Conjunctivitis—Doxorubicin—kidney cancer	3.73e-05	0.000151	CcSEcCtD
Topiramate—Urinary tract infection—Doxorubicin—kidney cancer	3.73e-05	0.000151	CcSEcCtD
Topiramate—Nervous system disorder—Capecitabine—kidney cancer	3.72e-05	0.000151	CcSEcCtD
Topiramate—Thrombocytopenia—Capecitabine—kidney cancer	3.72e-05	0.000151	CcSEcCtD
Topiramate—Tachycardia—Capecitabine—kidney cancer	3.7e-05	0.00015	CcSEcCtD
Topiramate—Vomiting—Vincristine—kidney cancer	3.7e-05	0.00015	CcSEcCtD
Topiramate—Skin disorder—Capecitabine—kidney cancer	3.69e-05	0.00015	CcSEcCtD
Topiramate—Urticaria—Paclitaxel—kidney cancer	3.67e-05	0.000149	CcSEcCtD
Topiramate—Rash—Vincristine—kidney cancer	3.67e-05	0.000149	CcSEcCtD
Topiramate—Hyperhidrosis—Capecitabine—kidney cancer	3.67e-05	0.000149	CcSEcCtD
Topiramate—Dermatitis—Vincristine—kidney cancer	3.67e-05	0.000149	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—kidney cancer	3.66e-05	0.000148	CcSEcCtD
Topiramate—Abdominal pain—Paclitaxel—kidney cancer	3.66e-05	0.000148	CcSEcCtD
Topiramate—Body temperature increased—Paclitaxel—kidney cancer	3.66e-05	0.000148	CcSEcCtD
Topiramate—Headache—Vincristine—kidney cancer	3.65e-05	0.000148	CcSEcCtD
Topiramate—Epistaxis—Doxorubicin—kidney cancer	3.62e-05	0.000147	CcSEcCtD
Topiramate—Anorexia—Capecitabine—kidney cancer	3.62e-05	0.000147	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—kidney cancer	3.6e-05	0.000146	CcSEcCtD
Topiramate—Agranulocytosis—Doxorubicin—kidney cancer	3.58e-05	0.000145	CcSEcCtD
Topiramate—Hypotension—Capecitabine—kidney cancer	3.55e-05	0.000144	CcSEcCtD
Topiramate—Vomiting—Gemcitabine—kidney cancer	3.51e-05	0.000143	CcSEcCtD
Topiramate—Bradycardia—Doxorubicin—kidney cancer	3.51e-05	0.000142	CcSEcCtD
Topiramate—Rash—Gemcitabine—kidney cancer	3.48e-05	0.000141	CcSEcCtD
Topiramate—Dermatitis—Gemcitabine—kidney cancer	3.48e-05	0.000141	CcSEcCtD
Topiramate—Haemoglobin—Doxorubicin—kidney cancer	3.46e-05	0.00014	CcSEcCtD
Topiramate—Headache—Gemcitabine—kidney cancer	3.46e-05	0.00014	CcSEcCtD
Topiramate—Nausea—Vincristine—kidney cancer	3.46e-05	0.00014	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.46e-05	0.00014	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—kidney cancer	3.45e-05	0.00014	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—kidney cancer	3.44e-05	0.00014	CcSEcCtD
Topiramate—Hepatitis—Doxorubicin—kidney cancer	3.44e-05	0.00014	CcSEcCtD
Topiramate—Insomnia—Capecitabine—kidney cancer	3.43e-05	0.000139	CcSEcCtD
Topiramate—Hypoaesthesia—Doxorubicin—kidney cancer	3.43e-05	0.000139	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—kidney cancer	3.42e-05	0.000139	CcSEcCtD
Topiramate—Paraesthesia—Capecitabine—kidney cancer	3.41e-05	0.000138	CcSEcCtD
Topiramate—Hypersensitivity—Paclitaxel—kidney cancer	3.41e-05	0.000138	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—kidney cancer	3.4e-05	0.000138	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—kidney cancer	3.39e-05	0.000138	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—kidney cancer	3.38e-05	0.000137	CcSEcCtD
Topiramate—Dyspnoea—Capecitabine—kidney cancer	3.38e-05	0.000137	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—kidney cancer	3.38e-05	0.000137	CcSEcCtD
Topiramate—Dyspepsia—Capecitabine—kidney cancer	3.34e-05	0.000136	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—kidney cancer	3.32e-05	0.000135	CcSEcCtD
Topiramate—Asthenia—Paclitaxel—kidney cancer	3.32e-05	0.000135	CcSEcCtD
Topiramate—Decreased appetite—Capecitabine—kidney cancer	3.3e-05	0.000134	CcSEcCtD
Topiramate—Nausea—Gemcitabine—kidney cancer	3.28e-05	0.000133	CcSEcCtD
Topiramate—Gastrointestinal disorder—Capecitabine—kidney cancer	3.28e-05	0.000133	CcSEcCtD
Topiramate—Fatigue—Capecitabine—kidney cancer	3.27e-05	0.000133	CcSEcCtD
Topiramate—Pruritus—Paclitaxel—kidney cancer	3.27e-05	0.000133	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—kidney cancer	3.26e-05	0.000132	CcSEcCtD
Topiramate—Pain—Capecitabine—kidney cancer	3.25e-05	0.000132	CcSEcCtD
Topiramate—Constipation—Capecitabine—kidney cancer	3.25e-05	0.000132	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—kidney cancer	3.22e-05	0.000131	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—kidney cancer	3.21e-05	0.00013	CcSEcCtD
Topiramate—Flushing—Doxorubicin—kidney cancer	3.2e-05	0.00013	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—kidney cancer	3.2e-05	0.00013	CcSEcCtD
Topiramate—Diarrhoea—Paclitaxel—kidney cancer	3.16e-05	0.000128	CcSEcCtD
Topiramate—Feeling abnormal—Capecitabine—kidney cancer	3.13e-05	0.000127	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—kidney cancer	3.12e-05	0.000127	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—kidney cancer	3.11e-05	0.000126	CcSEcCtD
Topiramate—Gastrointestinal pain—Capecitabine—kidney cancer	3.1e-05	0.000126	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—kidney cancer	3.1e-05	0.000126	CcSEcCtD
Topiramate—Chills—Doxorubicin—kidney cancer	3.09e-05	0.000125	CcSEcCtD
Topiramate—Dizziness—Paclitaxel—kidney cancer	3.06e-05	0.000124	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—kidney cancer	3.04e-05	0.000123	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—kidney cancer	3.02e-05	0.000122	CcSEcCtD
Topiramate—Urticaria—Capecitabine—kidney cancer	3.02e-05	0.000122	CcSEcCtD
Topiramate—Abdominal pain—Capecitabine—kidney cancer	3e-05	0.000122	CcSEcCtD
Topiramate—Body temperature increased—Capecitabine—kidney cancer	3e-05	0.000122	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—kidney cancer	3e-05	0.000122	CcSEcCtD
Topiramate—Erythema—Doxorubicin—kidney cancer	3e-05	0.000122	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—kidney cancer	2.95e-05	0.00012	CcSEcCtD
Topiramate—Tension—Doxorubicin—kidney cancer	2.94e-05	0.000119	CcSEcCtD
Topiramate—Vomiting—Paclitaxel—kidney cancer	2.94e-05	0.000119	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—kidney cancer	2.94e-05	0.000119	CcSEcCtD
Topiramate—Rash—Paclitaxel—kidney cancer	2.92e-05	0.000118	CcSEcCtD
Topiramate—Dermatitis—Paclitaxel—kidney cancer	2.91e-05	0.000118	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—kidney cancer	2.91e-05	0.000118	CcSEcCtD
Topiramate—Back pain—Doxorubicin—kidney cancer	2.9e-05	0.000118	CcSEcCtD
Topiramate—Headache—Paclitaxel—kidney cancer	2.9e-05	0.000118	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—kidney cancer	2.88e-05	0.000117	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—kidney cancer	2.83e-05	0.000115	CcSEcCtD
Topiramate—Hypersensitivity—Capecitabine—kidney cancer	2.8e-05	0.000113	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—kidney cancer	2.78e-05	0.000113	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—kidney cancer	2.77e-05	0.000112	CcSEcCtD
Topiramate—Agitation—Doxorubicin—kidney cancer	2.76e-05	0.000112	CcSEcCtD
Topiramate—Nausea—Paclitaxel—kidney cancer	2.75e-05	0.000111	CcSEcCtD
Topiramate—Asthenia—Capecitabine—kidney cancer	2.72e-05	0.000111	CcSEcCtD
Topiramate—Malaise—Doxorubicin—kidney cancer	2.7e-05	0.00011	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—kidney cancer	2.69e-05	0.000109	CcSEcCtD
Topiramate—Syncope—Doxorubicin—kidney cancer	2.69e-05	0.000109	CcSEcCtD
Topiramate—Pruritus—Capecitabine—kidney cancer	2.69e-05	0.000109	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—kidney cancer	2.68e-05	0.000109	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—kidney cancer	2.65e-05	0.000108	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—kidney cancer	2.63e-05	0.000107	CcSEcCtD
Topiramate—Cough—Doxorubicin—kidney cancer	2.62e-05	0.000106	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—kidney cancer	2.6e-05	0.000105	CcSEcCtD
Topiramate—Diarrhoea—Capecitabine—kidney cancer	2.6e-05	0.000105	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—kidney cancer	2.59e-05	0.000105	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—kidney cancer	2.55e-05	0.000104	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—kidney cancer	2.55e-05	0.000104	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—kidney cancer	2.55e-05	0.000104	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—kidney cancer	2.54e-05	0.000103	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.53e-05	0.000103	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—kidney cancer	2.52e-05	0.000102	CcSEcCtD
Topiramate—Dizziness—Capecitabine—kidney cancer	2.51e-05	0.000102	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—kidney cancer	2.5e-05	0.000101	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—kidney cancer	2.47e-05	0.0001	CcSEcCtD
Topiramate—Oedema—Doxorubicin—kidney cancer	2.45e-05	9.93e-05	CcSEcCtD
Topiramate—Infection—Doxorubicin—kidney cancer	2.43e-05	9.86e-05	CcSEcCtD
Topiramate—Vomiting—Capecitabine—kidney cancer	2.41e-05	9.79e-05	CcSEcCtD
Topiramate—Shock—Doxorubicin—kidney cancer	2.41e-05	9.77e-05	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—kidney cancer	2.4e-05	9.74e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—kidney cancer	2.4e-05	9.72e-05	CcSEcCtD
Topiramate—Rash—Capecitabine—kidney cancer	2.39e-05	9.71e-05	CcSEcCtD
Topiramate—Dermatitis—Capecitabine—kidney cancer	2.39e-05	9.7e-05	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—kidney cancer	2.39e-05	9.69e-05	CcSEcCtD
Topiramate—Headache—Capecitabine—kidney cancer	2.38e-05	9.65e-05	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—kidney cancer	2.38e-05	9.64e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Doxorubicin—kidney cancer	2.37e-05	9.6e-05	CcSEcCtD
Topiramate—CA7—Metabolism—GSTP1—kidney cancer	2.34e-05	0.000204	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS1—kidney cancer	2.33e-05	0.000204	CbGpPWpGaD
Topiramate—Anorexia—Doxorubicin—kidney cancer	2.33e-05	9.46e-05	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.3e-05	0.000201	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTM1—kidney cancer	2.3e-05	0.000201	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTM1—kidney cancer	2.3e-05	0.000201	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—kidney cancer	2.29e-05	0.0002	CbGpPWpGaD
Topiramate—CA1—Metabolism—ACHE—kidney cancer	2.29e-05	0.0002	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSMD7—kidney cancer	2.29e-05	0.0002	CbGpPWpGaD
Topiramate—Hypotension—Doxorubicin—kidney cancer	2.29e-05	9.28e-05	CcSEcCtD
Topiramate—CYP2C19—Biological oxidations—GSTP1—kidney cancer	2.28e-05	0.000199	CbGpPWpGaD
Topiramate—CA2—Metabolism—SCARB1—kidney cancer	2.26e-05	0.000197	CbGpPWpGaD
Topiramate—Nausea—Capecitabine—kidney cancer	2.25e-05	9.15e-05	CcSEcCtD
Topiramate—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	2.25e-05	0.000197	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.25e-05	0.000197	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	2.24e-05	0.000196	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS1—kidney cancer	2.24e-05	0.000195	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MAPK3—kidney cancer	2.23e-05	0.000195	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MAPK3—kidney cancer	2.23e-05	0.000195	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.23e-05	9.05e-05	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	2.23e-05	0.000194	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.23e-05	0.000194	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—BRAF—kidney cancer	2.21e-05	0.000193	CbGpPWpGaD
Topiramate—Insomnia—Doxorubicin—kidney cancer	2.21e-05	8.98e-05	CcSEcCtD
Topiramate—CA7—Metabolism—ABCB1—kidney cancer	2.21e-05	0.000193	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—kidney cancer	2.21e-05	0.000193	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—RAF1—kidney cancer	2.21e-05	0.000193	CbGpPWpGaD
Topiramate—CA9—Metabolism—ITPR2—kidney cancer	2.21e-05	0.000193	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	2.2e-05	0.000192	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—RELA—kidney cancer	2.2e-05	0.000192	CbGpPWpGaD
Topiramate—Paraesthesia—Doxorubicin—kidney cancer	2.2e-05	8.92e-05	CcSEcCtD
Topiramate—CA2—Metabolism—PSMD7—kidney cancer	2.19e-05	0.000192	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—ERBB2—kidney cancer	2.18e-05	0.000191	CbGpPWpGaD
Topiramate—Dyspnoea—Doxorubicin—kidney cancer	2.18e-05	8.85e-05	CcSEcCtD
Topiramate—CA6—Metabolism—CYP1A1—kidney cancer	2.18e-05	0.00019	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1A1—kidney cancer	2.18e-05	0.00019	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—RAF1—kidney cancer	2.18e-05	0.00019	CbGpPWpGaD
Topiramate—Somnolence—Doxorubicin—kidney cancer	2.18e-05	8.83e-05	CcSEcCtD
Topiramate—CA4—Metabolism—BCHE—kidney cancer	2.17e-05	0.000189	CbGpPWpGaD
Topiramate—CA1—Metabolism—SCARB1—kidney cancer	2.17e-05	0.000189	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTP1—kidney cancer	2.16e-05	0.000189	CbGpPWpGaD
Topiramate—Dyspepsia—Doxorubicin—kidney cancer	2.15e-05	8.74e-05	CcSEcCtD
Topiramate—SCN5A—Axon guidance—ERBB2—kidney cancer	2.15e-05	0.000188	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KDR—kidney cancer	2.15e-05	0.000188	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTM1—kidney cancer	2.15e-05	0.000188	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTM1—kidney cancer	2.15e-05	0.000188	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS1—kidney cancer	2.14e-05	0.000187	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC5A5—kidney cancer	2.14e-05	0.000187	CbGpPWpGaD
Topiramate—Decreased appetite—Doxorubicin—kidney cancer	2.13e-05	8.63e-05	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.13e-05	0.000186	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—MAPK1—kidney cancer	2.12e-05	0.000185	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.11e-05	8.57e-05	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—kidney cancer	2.11e-05	8.56e-05	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	2.11e-05	0.000184	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSMD7—kidney cancer	2.1e-05	0.000184	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MET—kidney cancer	2.1e-05	0.000184	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTM1—kidney cancer	2.1e-05	0.000183	CbGpPWpGaD
Topiramate—Pain—Doxorubicin—kidney cancer	2.09e-05	8.49e-05	CcSEcCtD
Topiramate—Constipation—Doxorubicin—kidney cancer	2.09e-05	8.49e-05	CcSEcCtD
Topiramate—CA2—Metabolism—BCHE—kidney cancer	2.08e-05	0.000182	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.07e-05	0.000181	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC2A1—kidney cancer	2.07e-05	0.000181	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	2.07e-05	0.000181	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC5A5—kidney cancer	2.05e-05	0.000179	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—kidney cancer	2.05e-05	0.000179	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1A1—kidney cancer	2.04e-05	0.000178	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1A1—kidney cancer	2.04e-05	0.000178	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—RAF1—kidney cancer	2.02e-05	0.000177	CbGpPWpGaD
Topiramate—Feeling abnormal—Doxorubicin—kidney cancer	2.02e-05	8.18e-05	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.01e-05	0.000176	CbGpPWpGaD
Topiramate—CA9—Metabolism—ACHE—kidney cancer	2.01e-05	0.000176	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTT1—kidney cancer	2.01e-05	0.000176	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—KRAS—kidney cancer	2e-05	0.000175	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Doxorubicin—kidney cancer	2e-05	8.12e-05	CcSEcCtD
Topiramate—CA1—Metabolism—BCHE—kidney cancer	1.99e-05	0.000174	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTM1—kidney cancer	1.99e-05	0.000174	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	1.99e-05	0.000174	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC2A1—kidney cancer	1.98e-05	0.000173	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.98e-05	0.000173	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC5A5—kidney cancer	1.97e-05	0.000172	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	1.96e-05	0.000171	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	1.96e-05	0.000171	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.94e-05	0.00017	CbGpPWpGaD
Topiramate—Urticaria—Doxorubicin—kidney cancer	1.94e-05	7.89e-05	CcSEcCtD
Topiramate—GABRA1—Neuronal System—BRAF—kidney cancer	1.94e-05	0.000169	CbGpPWpGaD
Topiramate—Abdominal pain—Doxorubicin—kidney cancer	1.93e-05	7.85e-05	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—kidney cancer	1.93e-05	7.85e-05	CcSEcCtD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	1.92e-05	0.000168	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.92e-05	0.000168	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—kidney cancer	1.91e-05	0.000167	CbGpPWpGaD
Topiramate—CA9—Metabolism—SCARB1—kidney cancer	1.9e-05	0.000166	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC2A1—kidney cancer	1.9e-05	0.000166	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS1—kidney cancer	1.89e-05	0.000165	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A1—kidney cancer	1.89e-05	0.000165	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.86e-05	0.000162	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSMD7—kidney cancer	1.85e-05	0.000162	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—RAF1—kidney cancer	1.85e-05	0.000161	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MAPK1—kidney cancer	1.85e-05	0.000161	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.81e-05	0.000158	CbGpPWpGaD
Topiramate—Hypersensitivity—Doxorubicin—kidney cancer	1.8e-05	7.32e-05	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—TP53—kidney cancer	1.78e-05	0.000156	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.76e-05	0.000153	CbGpPWpGaD
Topiramate—Asthenia—Doxorubicin—kidney cancer	1.76e-05	7.12e-05	CcSEcCtD
Topiramate—CA9—Metabolism—BCHE—kidney cancer	1.75e-05	0.000153	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACY1—kidney cancer	1.75e-05	0.000153	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC5A5—kidney cancer	1.73e-05	0.000151	CbGpPWpGaD
Topiramate—Pruritus—Doxorubicin—kidney cancer	1.73e-05	7.02e-05	CcSEcCtD
Topiramate—CA4—Metabolism—GSTP1—kidney cancer	1.73e-05	0.000151	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—kidney cancer	1.68e-05	0.000147	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.68e-05	0.000147	CbGpPWpGaD
Topiramate—Diarrhoea—Doxorubicin—kidney cancer	1.67e-05	6.79e-05	CcSEcCtD
Topiramate—CA9—Metabolism—SLC2A1—kidney cancer	1.67e-05	0.000146	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—kidney cancer	1.66e-05	0.000145	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.65e-05	0.000145	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—kidney cancer	1.65e-05	0.000145	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—kidney cancer	1.63e-05	0.000143	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—kidney cancer	1.63e-05	0.000142	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—kidney cancer	1.63e-05	0.000142	CbGpPWpGaD
Topiramate—Dizziness—Doxorubicin—kidney cancer	1.62e-05	6.57e-05	CcSEcCtD
Topiramate—GABRA1—Neuronal System—RAF1—kidney cancer	1.62e-05	0.000141	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK3—kidney cancer	1.59e-05	0.000139	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—kidney cancer	1.59e-05	0.000139	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—kidney cancer	1.59e-05	0.000139	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK3—kidney cancer	1.57e-05	0.000137	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—kidney cancer	1.57e-05	0.000137	CbGpPWpGaD
Topiramate—Vomiting—Doxorubicin—kidney cancer	1.56e-05	6.31e-05	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—RAF1—kidney cancer	1.55e-05	0.000136	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—RELA—kidney cancer	1.55e-05	0.000135	CbGpPWpGaD
Topiramate—Rash—Doxorubicin—kidney cancer	1.54e-05	6.26e-05	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—kidney cancer	1.54e-05	6.25e-05	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—ERBB2—kidney cancer	1.54e-05	0.000134	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.54e-05	0.000134	CbGpPWpGaD
Topiramate—Headache—Doxorubicin—kidney cancer	1.53e-05	6.22e-05	CcSEcCtD
Topiramate—CA2—Metabolism—GSTM1—kidney cancer	1.52e-05	0.000133	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—kidney cancer	1.52e-05	0.000133	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—kidney cancer	1.52e-05	0.000133	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MAPK1—kidney cancer	1.51e-05	0.000132	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A1—kidney cancer	1.5e-05	0.000131	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—kidney cancer	1.5e-05	0.000131	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MAPK1—kidney cancer	1.49e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.49e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PDHB—kidney cancer	1.49e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—kidney cancer	1.48e-05	0.00013	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—kidney cancer	1.46e-05	0.000127	CbGpPWpGaD
Topiramate—Nausea—Doxorubicin—kidney cancer	1.45e-05	5.9e-05	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.45e-05	0.000126	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A1—kidney cancer	1.44e-05	0.000126	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—kidney cancer	1.43e-05	0.000125	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—kidney cancer	1.41e-05	0.000123	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—kidney cancer	1.41e-05	0.000123	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CCBL1—kidney cancer	1.4e-05	0.000122	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—kidney cancer	1.39e-05	0.000122	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAPK1—kidney cancer	1.39e-05	0.000121	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1A1—kidney cancer	1.38e-05	0.000121	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.37e-05	0.00012	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.35e-05	0.000118	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—kidney cancer	1.34e-05	0.000117	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—kidney cancer	1.32e-05	0.000115	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—kidney cancer	1.3e-05	0.000113	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—kidney cancer	1.3e-05	0.000113	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—kidney cancer	1.28e-05	0.000112	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAPK1—kidney cancer	1.27e-05	0.000111	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.26e-05	0.00011	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.26e-05	0.00011	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.24e-05	0.000109	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A1—kidney cancer	1.21e-05	0.000106	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPAT—kidney cancer	1.21e-05	0.000106	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.21e-05	0.000106	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—kidney cancer	1.21e-05	0.000106	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—kidney cancer	1.21e-05	0.000106	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.2e-05	0.000105	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.2e-05	0.000104	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.19e-05	0.000104	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—kidney cancer	1.18e-05	0.000103	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.18e-05	0.000103	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—kidney cancer	1.13e-05	9.88e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—kidney cancer	1.13e-05	9.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APRT—kidney cancer	1.13e-05	9.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FH—kidney cancer	1.13e-05	9.85e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—kidney cancer	1.12e-05	9.79e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—kidney cancer	1.12e-05	9.79e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—kidney cancer	1.12e-05	9.78e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAPK1—kidney cancer	1.11e-05	9.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.1e-05	9.62e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.09e-05	9.49e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—kidney cancer	1.07e-05	9.39e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK1—kidney cancer	1.06e-05	9.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPC3—kidney cancer	1.06e-05	9.26e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—kidney cancer	1.06e-05	9.22e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—kidney cancer	1.06e-05	9.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACY1—kidney cancer	1.05e-05	9.19e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA2—kidney cancer	1.03e-05	9.01e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—kidney cancer	1.03e-05	9e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—kidney cancer	1.01e-05	8.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALAD—kidney cancer	1e-05	8.78e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	9.94e-06	8.68e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ST3GAL2—kidney cancer	9.81e-06	8.57e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—kidney cancer	9.78e-06	8.54e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH1A1—kidney cancer	9.59e-06	8.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PGK1—kidney cancer	9.19e-06	8.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A3—kidney cancer	9.19e-06	8.03e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—kidney cancer	9.06e-06	7.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LDHB—kidney cancer	9.01e-06	7.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PDHB—kidney cancer	8.94e-06	7.81e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—kidney cancer	8.94e-06	7.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—kidney cancer	8.92e-06	7.79e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.69e-06	7.59e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—kidney cancer	8.57e-06	7.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CCBL1—kidney cancer	8.41e-06	7.35e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—kidney cancer	8.22e-06	7.18e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—kidney cancer	7.98e-06	6.97e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—kidney cancer	7.98e-06	6.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA9—kidney cancer	7.81e-06	6.83e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—kidney cancer	7.8e-06	6.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.64e-06	6.67e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—kidney cancer	7.48e-06	6.53e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—kidney cancer	7.45e-06	6.5e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—kidney cancer	7.45e-06	6.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPAT—kidney cancer	7.29e-06	6.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.29e-06	6.37e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—kidney cancer	7.23e-06	6.31e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—kidney cancer	7.17e-06	6.26e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—kidney cancer	6.9e-06	6.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FH—kidney cancer	6.78e-06	5.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APRT—kidney cancer	6.78e-06	5.92e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CRABP1—kidney cancer	6.64e-06	5.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPC3—kidney cancer	6.37e-06	5.57e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—kidney cancer	6.3e-06	5.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA2—kidney cancer	6.2e-06	5.42e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ITPR2—kidney cancer	6.18e-06	5.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALAD—kidney cancer	6.04e-06	5.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.9e-06	5.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.76e-06	5.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.69e-06	4.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—kidney cancer	5.63e-06	4.92e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACHE—kidney cancer	5.63e-06	4.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.53e-06	4.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PGK1—kidney cancer	5.53e-06	4.83e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—kidney cancer	5.5e-06	4.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDHB—kidney cancer	5.42e-06	4.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SCARB1—kidney cancer	5.33e-06	4.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS1—kidney cancer	5.28e-06	4.61e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—kidney cancer	5.27e-06	4.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMD7—kidney cancer	5.18e-06	4.52e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—kidney cancer	5.06e-06	4.42e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—kidney cancer	4.91e-06	4.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.85e-06	4.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA9—kidney cancer	4.7e-06	4.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.68e-06	4.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.54e-06	3.97e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—kidney cancer	4.45e-06	3.88e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CRABP1—kidney cancer	4e-06	3.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.96e-06	3.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—kidney cancer	3.9e-06	3.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ITPR2—kidney cancer	3.71e-06	3.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—kidney cancer	3.7e-06	3.23e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—kidney cancer	3.59e-06	3.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.4e-06	2.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACHE—kidney cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—kidney cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SCARB1—kidney cancer	3.21e-06	2.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS1—kidney cancer	3.17e-06	2.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMD7—kidney cancer	3.11e-06	2.72e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—kidney cancer	2.95e-06	2.58e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.91e-06	2.55e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.81e-06	2.46e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.79e-06	2.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—kidney cancer	2.54e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—kidney cancer	2.35e-06	2.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—kidney cancer	2.22e-06	1.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—kidney cancer	2.16e-06	1.88e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.05e-06	1.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—kidney cancer	2.02e-06	1.77e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—kidney cancer	1.76e-06	1.54e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—kidney cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.24e-06	1.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—kidney cancer	1.22e-06	1.06e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—kidney cancer	1.06e-06	9.27e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.48e-07	6.54e-06	CbGpPWpGaD
